Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 26, 1152-1160, June 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aisenberg, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aisenberg, A. C.

Manifestations of Immunologic Unresponsiveness in Hodgkin's Disease1

Alan C. Aisenberg

Massachusetts General Hospital, Boston, Massachusetts

The immunologic defect of early Hodgkin's disease is characterized by a depression of delayed hypersensitivity and can be assessed by negative reactions to a battery of delayed allergens or by inability to acquire contact sensitivity. While the homograft reaction is depressed in these patients, antibody formation is largely intact and the lymphocyte count is normal or but slightly depressed. It is suggested that the anergy of early Hodgkin's disease is a peripheral defect; a manifestation of abnormal lymphocyte function. This suggestion is supported by preliminary work with Hodgkin's lymphocytes in vitro and following lymphocyte transfer. Later in the course of the condition profound lymphopenia develops and most probably contributes to the more severe and complex immunologic deficiencies of advanced Hodgkin's disease.

1 The author's work is supported by Research Grant CA-07179 of the National Cancer Institute, USPHS. This is Publication 1231 of the Cancer Commission of Harvard University.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1966 by the American Association for Cancer Research.